Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Benchmark Holdings plc
  6. Company
    BMK   GB00BGHPT808

BENCHMARK HOLDINGS PLC

(BMK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Benchmark Holdings plc is engaged in the provision of aquaculture health, genetics and nutrition. The CompanyÔÇÖs segments include genetics, advanced nutrition and health. The Company develops products that helps fish and shrimp to improve their sustainability and profitability by improving yield, quality, and by reducing mortality. The CompanyÔÇÖs products include high genetic quality ova for salmon, shrimp and tilapia, and breeding, program, specialist feeds for early stage shrimp and fish; probiotics, biocides and medicines.

Number of employees : 815 people.
Sales per Business
20192020Delta
GBP (in Million)%GBP (in Million)%
Advanced Nutrition76.7860.3%59.3656.2% -22.68%
Genetics39.7031.2%41.5039.3% +4.55%
Health17.7413.9%10.8010.2% -39.13%
All Other15.8812.5%9.268.8% -41.71%
Corporate6.535.1%4.944.7% -24.41%
Sales per region
2020
GBP (in Million)%
Rest of World33.1031.4%
Norway20.8119.7%
Rest of Europe10.029.5%
United Kingdom7.146.8%
Faroe Islands7.086.7%
Ecuador6.826.5%
India6.466.1%
Greece5.735.4%
Singapore5.365.1%
Chile3.062.9%
Managers
NameAgeSinceTitle
Trond Ivar Williksen572020Chief Executive Officer & Executive Director
Septima Maguire432019Chief Financial Officer & Executive Director
Susan Jane Searle562013Senior Independent Non-Executive Director
Kevin Quinn61-Independent Non-Executive Director
Yngve Myhre512017Independent Non-Executive Director
Peter George Lutz592020Non-Executive Chairman
Ivonne Cantu512017Director-Corporate Development
Jennifer Haddouk--Secretary & Group Legal Counsel
Doerte Laue--Marketing Director
Athene Blakeman--Head-Advanced Nutrition
Members of the board
NameAgeSinceTitle
Peter George Lutz592020Non-Executive Chairman
Susan Jane Searle562013Senior Independent Non-Executive Director
Kevin Quinn61-Independent Non-Executive Director
Yngve Myhre512017Independent Non-Executive Director
Kristian Eikre422019Non-Executive Director
Septima Maguire432019Chief Financial Officer & Executive Director
Trond Ivar Williksen572020Chief Executive Officer & Executive Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 670,192,800 499,317,748 74.5% 0 0.0% 74.5%
Shareholders
NameEquities%
Ferd Invest AS 173,331,185 25.9%
Gustav Witz°e 129,179,564 19.3%
JNE Partners LLP 111,570,266 16.6%
Lansdowne Partners (UK) LLP 40,461,748 6.04%
RBS Collective Investment Funds Ltd. 32,396,158 4.83%
Canaccord Genuity Wealth Ltd. 23,870,000 3.56%
Harwood Capital LLP 23,121,657 3.45%
DNB Asset Management AS 17,367,500 2.59%
Malcolm David Foster Pye 15,171,176 2.26%
GVQ Investment Management Ltd. 15,052,024 2.25%
Company contact information
Benchmark Holdings Plc
Benchmark House
8 Smithy Wood Drive
Sheffield, South Yorkshire S35 1QN

Phone : +44.114.2409939
Web : http://benchmarkplc.com
Sector Other Pharmaceuticals
1st jan.Capitalization (M$)
BENCHMARK HOLDINGS PLC-9.45%532
JOHNSON & JOHNSON2.92%426 557
ROCHE HOLDING AG12.70%325 803
PFIZER, INC.5.43%217 246
NOVARTIS AG2.47%208 642
ABBVIE INC.5.57%199 795
ELI LILLY AND COMPANY29.44%198 668
MERCK & CO., INC.-6.34%193 981
NOVO NORDISK A/S20.59%188 360
ASTRAZENECA PLC14.47%151 865
BRISTOL-MYERS SQUIBB COMPANY7.16%148 417
AMGEN INC.3.81%137 135
SANOFI11.79%130 457
GLAXOSMITHKLINE PLC6.07%98 277
JIANGSU HENGRUI MEDICINE CO., LTD.-23.09%70 523
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-22.77%63 368
BAYER AG9.54%61 438
TAKEDA PHARMACEUTICAL COMPANY LIMITED-0.85%52 846
DAIICHI SANKYO COMPANY, LIMITED-28.98%43 629
ASTELLAS PHARMA INC.21.89%32 733